---
layout: startup_page
title: "En Carta Diagnostics"
id: "encarta.bio"
permalink: "/encartadiagnosticsencarta.bio04182025/"
website: "https://www.encarta.bio/"
funding_round: "Pre-Seed"
funding_amount: "€1.5M"
investors: "CentraleSupélec Venture, a handful of high-profile business angels"
about: "En Carta Diagnostics develops rapid Point-of-Care (POC) molecular diagnostics kits using aptamers. Their initial focus is on Lyme disease, addressing the limitations of current antibody-based tests with a platform capable of early and accurate diagnosis. The technology has broader applications across various genetic, pathogenic, and veterinary indications."
markets: "Healthtech, Diagnostics, Biotechnology Research"
hq: "Paris, , France"
founded_year: "2022"
linkedin: "https://www.linkedin.com/company/en-carta-diagnostics"
twitter: ""
instagram: ""
facebook: ""
crunchbase: "https://www.crunchbase.com/organization/en-carta-diagnostics?utm_source=linkedin&utm_medium=referral&utm_campaign=linkedin_companies&utm_content=profile_cta_anon&trk=funding_crunchbase"
pitchbook: "https://pitchbook.com/profiles/company/517650-85"

# SEO Optimization
meta_title: "En Carta Diagnostics - Pre-Seed Funding (€1.5M)"
meta_description: "En Carta Diagnostics, En Carta Diagnostics develops rapid Point-of-Care (POC) molecular diagnostics kits using aptamers. Their initial focus is on Lyme disease, addressing ..."
meta_keywords: "En Carta Diagnostics, Healthtech, Diagnostics, Biotechnology Research, Pre-Seed funding"
canonical_url: "https://pkprojectstartups.github.io/projectstartups.com/encartadiagnosticsencarta.bio04182025/"
---